» Articles » PMID: 26793317

Approach to Hyponatremia in Congestive Heart Failure: a Survey of Canadian Specialist Physicians and Trainees

Overview
Publisher Sage Publications
Date 2016 Jan 22
PMID 26793317
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hyponatremia is a recognized complication of congestive heart failure (CHF) and is associated with reduced survival. Therefore, early identification and appropriate management of hyponatremia is important. The aim of this study was to determine the general approach amongst Canadian healthcare practitioners and trainees to the identification and management of hyponatremia complicating CHF.

Methods: Respondents completed 15 multiple-choice style questions in 3 case scenarios regarding the approach to management of hyponatremia complicating CHF using an online survey on UKidney.com between November 2012 and May 2013. Results were presented as a proportion of averaged correct/incorrect responses amongst Canadian nephrologists, cardiologists, internists and trainees in each of two domains; pathophysiology and management. Management was further subdivided into correct and incorrect use of diuretic therapy, hypertonic saline, oral urea tablets, vasopressin receptor antagonists (vaptans) and rate of sodium correction. Correct responses were determined by an expert panel of Canadian nephrologists and cardiologists based on review of evidence informed guidelines and current recommendations.

Results: There were 1757 responses to our online survey amongst 455 Canadian respondents, 1139 of which were from cardiologists, nephrologists, general internists, or trainees. Overall, the pathophysiology governing hyponatremia in CHF was correctly identified 68.7 % of the time (n = 380 responses, averaged over 4 questions). Hyponatremia was managed inappropriately 43.6 % of the time, with trainees scoring best overall with correct responses 60.3 % of the time (n = 759 responses, over 11 questions). Importantly, an incorrect rate for sodium correction was selected 61.1 % of the time overall, (n = 211 responses, averaged over 3 questions).

Conclusions: This study identified that there are differences in the understanding of pathophysiology and management strategies for hyponatremia in the context of CHF amongst Canadian specialist physicians and trainees. A more consistent approach to hyponatremia is required and might best be achieved through formal knowledge translation.

Citing Articles

Progressive kidney disease may not alter the association of hyponatremia with mortality.

Golestaneh L, Neugarten J, Kaskel F, McGinn A Clin Exp Nephrol. 2018; 22(4):889-897.

PMID: 29396621 DOI: 10.1007/s10157-018-1536-8.


Improving the diagnostic workup of hyponatremia in the setting of kidney disease: a continuing medical education (CME) initiative.

Golestaneh L, Neugarten J, Southern W, Kargoli F, Raff A Int Urol Nephrol. 2017; 49(3):491-497.

PMID: 28091865 DOI: 10.1007/s11255-017-1501-6.

References
1.
Chassagne P, Druesne L, Capet C, Menard J, Bercoff E . Clinical presentation of hypernatremia in elderly patients: a case control study. J Am Geriatr Soc. 2006; 54(8):1225-30. DOI: 10.1111/j.1532-5415.2006.00807.x. View

2.
Bourdel-Marchasson I, Laksir H, Puget E . Interpreting routine biochemistry in those aged over 65 years: a time for change. Maturitas. 2010; 66(1):39-45. DOI: 10.1016/j.maturitas.2010.02.004. View

3.
Hawkins R . Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003; 337(1-2):169-72. DOI: 10.1016/j.cccn.2003.08.001. View

4.
Soiza R, Cumming K, Clarke J, Wood K, Myint P . Hyponatremia: Special Considerations in Older Patients. J Clin Med. 2015; 3(3):944-58. PMC: 4449639. DOI: 10.3390/jcm3030944. View

5.
Ghali J, Tam S . The critical link of hypervolemia and hyponatremia in heart failure and the potential role of arginine vasopressin antagonists. J Card Fail. 2010; 16(5):419-31. DOI: 10.1016/j.cardfail.2009.12.021. View